HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 129 filers reported holding HARROW HEALTH INC in Q3 2023. The put-call ratio across all filers is 5.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,308 | -79.9% | 787 | -73.4% | 0.00% | – |
| Q2 2023 | $56,392 | -96.0% | 2,962 | -95.5% | 0.00% | -100.0% |
| Q1 2023 | $1,399,006 | +210.6% | 66,112 | +116.5% | 0.00% | +200.0% |
| Q4 2022 | $450,472 | +32.5% | 30,542 | +8.4% | 0.00% | 0.0% |
| Q3 2022 | $340,000 | +65.9% | 28,182 | 0.0% | 0.00% | – |
| Q2 2022 | $205,000 | -82.6% | 28,182 | +17850.3% | 0.00% | -100.0% |
| Q1 2022 | $1,176,000 | +39100.0% | 157 | -49.5% | 0.00% | – |
| Q4 2021 | $3,000 | -93.5% | 311 | -93.8% | 0.00% | – |
| Q3 2021 | $46,000 | -56.2% | 5,039 | -55.5% | 0.00% | – |
| Q2 2021 | $105,000 | +101.9% | 11,311 | +48.0% | 0.00% | – |
| Q1 2021 | $52,000 | +2.0% | 7,645 | +3.2% | 0.00% | – |
| Q4 2020 | $51,000 | +24.4% | 7,407 | -0.2% | 0.00% | – |
| Q3 2020 | $41,000 | -4.7% | 7,422 | -8.5% | 0.00% | – |
| Q2 2020 | $43,000 | +19.4% | 8,115 | -8.1% | 0.00% | – |
| Q1 2020 | $36,000 | – | 8,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,140,000 | $29,171,000 | 4.84% |
| Ophir Asset Management Pty Ltd | 1,670,817 | $15,522,000 | 2.73% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 378,389 | $3,515,000 | 1.16% |
| Birchview Capital, LP | 180,000 | $1,672,000 | 1.00% |
| Diametric Capital, LP | 82,443 | $766,000 | 0.55% |
| Precision Wealth Strategies, LLC | 65,530 | $609,000 | 0.52% |
| Uniplan Investment Counsel, Inc. | 507,602 | $4,715,000 | 0.28% |
| BARD ASSOCIATES INC | 86,315 | $802,000 | 0.26% |
| EAM Investors, LLC | 142,272 | $1,322,000 | 0.20% |
| Zebra Capital Management LLC | 15,786 | $147,000 | 0.17% |